OTHER NEWS - Aug. 14, 1991

ICN Seeks OK for New Use of Antiviral Drug: ICN Pharmaceuticals Inc. of Costa Mesa has applied to the Food and Drug Administration for permission to use the drug Virazole to combat the Hantaan virus, which can cause kidney failure in humans. The rodent-borne disease is uncommon in the United States, but affects about 350,000 people each year, mostly in poorer countries, said Jack Sholl, an ICN spokesman. It is fatal in about 18% to 35% of the cases. The application was made through ICN’s Viratek subsidiary.